Industry Orgs Applaud Bill to Boost Bars, Restaurants and Venues with Draft Systems
March 11, 2024 14:21 ET
|
Beer Institute
WASHINGTON, March 11, 2024 (GLOBE NEWSWIRE) -- Today, the Beer Institute, the oldest national trade association representing the beer industry, released the following statement after Reps. Darin...
Asia-Pacific's Next-Generation IVD Market Worth $42+ Billion by 2033: Key Insights by Type, End-user and Country
March 08, 2024 10:04 ET
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Next-Generation IVD Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The...
United States Medical Diagnostics Analysis Report 2024-2028: Growing Burden of Chronic Diseases, Escalating Use of EHR Systems and Rising Healthcare Expenditure Driving Growth
March 07, 2024 05:51 ET
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has...
Europe Medical Diagnostics Analysis Report 2024: A $109.91 Billion Market by 2028 with Focus on Immunoassays, Clinical Chemistry, Haematology & Coagulation
March 07, 2024 05:20 ET
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Europe Medical Diagnostics Market (Immunoassays, Clinical Chemistry, Haematology & Coagulation): Insights & Forecast with Potential Impact of...
Global COVID-19 Diagnostics Market Research Report 2024
February 29, 2024 04:40 ET
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global COVID-19 Diagnostics Market Forecast by Technology, Product, Channel and Country: Assay Volumes and 5-Year Market Size Outlook" report has been...
BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
February 27, 2024 15:52 ET
|
BioAegis Therapeutics
BioAegis announces global Phase 2 study of its inflammation regulator protein, gelsolin, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
Infectious Disease Diagnostics Market Analysis Reveals Surge in DTC Testing Approaches amid COVID-19
February 23, 2024 06:32 ET
|
Research and Markets
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market...
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
February 21, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced...
Global Marine Biotechnology Strategic Business Report 2024: Market to Reach $13.1 Billion by 2030 - Focus on Biofuels as the Future Energy Security Solution Drives Strong Demand
February 21, 2024 06:12 ET
|
Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Marine Biotechnology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Marine Biotechnology Market...
Europe Next Generation IVD Market Analysis and Forecast, 2023-2033 - A $40.41 Billion Market by 2033, Growing at a CAGR of 5.26% between 2023 and 2033
February 16, 2024 04:47 ET
|
Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "Europe Next Generation IVD Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Europe...